Areas of Therapeutic/ Clinical  Research:

  • Prevention: Vacines 

  • Testing 

  • Antivirals

  • Immuneregulators

  • Host-directed therapies

  • Supportive treatment

Patents vs. the Pandemic

We now have a choice between two futures. In the first scenario, we continue as usual, relying on the big pharmaceutical companies, hoping that some potential treatment for COVID-19 will make it through clinical trials, and that other technologies for detection, testing, and protection will emerge.​

In the second possible future, we would acknowledge that the current system – in which private monopolies profit from knowledge that is largely produced by public institutions – is not fit for purpose.

Plant-based Phytocannabinoids in the Management of Covid-19 Hyperinflammatory Response. A research Proposal (Leave this website) 

Research: The Coronavirus (SARS-CoV-2) and  the COVID-19 Pandemic  


This section  focuses  on  research associated with the Coronavirus (SARS-CoV-2) and  the  COVID-19 Pandemic 


  • Provide information about current research of Coronavirus  (SARS-CoV-2),

  • Explore gaps in existing knowledge 

  • Suggest ideas for research

  • Develop a crowdsourced network 

Overall Approach:

It is extraordinarily difficult to conduct randomized, controlled trials in the setting of an outbreak. Such trials are logistically complex, take a substantial amount of time to launch, and raise complex ethical considerations in the context of a rapidly spreading, highly fatal disease. But they provide the best data to guide treatment. Trials are particularly difficult to plan and execute during an epidemic in which shifting background care has a potential benefit with regard to outcomes. Using ethical considerations the justification and feasibility of a randomized design has been called into question.

Currently, there are many trials are underway to find the best interventions along the natural course of  COVID  19, from vaccines to target the virus, enhancing the immune function, 

treating the symptoms caused by the virus and related nonpharmacologic treatment. 


The current circumstances of the deepening pandemic provide an opportunity for a different way to study the risks and potential for external cannabinoids (plant-based phytocannabinoids) in the severely ill individual suffering from COVID  19. The current reality calls for experimentations using different approaches and guidelines for clinical trials.  WHO  launches a multinational trial to jumpstart the search for coronavirus drugs, the US Federal Government “slashed red tape” to expand trials.  A recent infogram summarized current research on COVID 19. 

Research Use Only 2019-Novel Coronavirus (2019-nCoV) Real-time RT-PCR Primer and Probe Information


March 13, 2020:  WHO to launch a multinational trial to jumpstart the search for coronavirus drugs

The Academic and Research Ecosystem


Starting   February 29th, 2021

Help us explore the role of the Academic and Research Community